Latest Nicholas J. Vogelzang Stories
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
Final data after 49-month follow-up analysis in chemotherapy-naïve men with metastatic castration-resistant prostate cancer presented at European Society for Medical Oncology (ESMO) 2014 Congress
Final analysis of Phase 3 COU-AA-302 study presented at the European Society for Medical Oncology (ESMO) 2014 Congress HORSHAM, Pa., Sept.
Researchers say pemetrexed (Alimta), the top chemotherapy drug for mesothelioma, may carry a risk of acute kidney injury, even in patients whose baseline kidney function falls within recommended
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Phase 2 study data presented at the 50th annual meeting of the American Society of Clinical Oncology HORSHAM, Pa., June 2, 2014 /PRNewswire/ -- Abiraterone acetate (ZYTIGA(®)) plus
Appointees join Caris' distinguished clinical and scientific team to accelerate the development and commercialization of innovative precision medicine technologies IRVING,
Two Studies Presented at 2014 AUA Annual Meeting SAN DIEGO, May 20, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced the presentation of data showing that its Decipher®
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.